Shares of Natural Health Trends Corp. (NHTC Quick QuoteNHTC - Free Report) have lost 12.4% since the company reported its earnings for the quarter ended Sept. 30, 2026, compared with the S&P 500 Index’s 2.4% decline over the same period. Over the past month, the stock has lost 20.7%, underperforming the broader market, which registered a 3.4% decrease.

Natural Health’s Earnings Snapshot

Natural Health reported third-quarter 2026 revenues of $7.6 million, down 20.2% from $9.5 million in the year-ago quarter. The company incurred a net loss of $0.2 million, or 3 cents per share, compared with $0.4 million, or 4 cents per diluted share, a year earlier.

The Primary Reporting Unit generated revenues of $7.3 million compared with $9.1 million a year ago. China revenues declined 42.6% to $0.1 million from $0.2 million, while Russia and Kazakhstan revenues also decreased 21.9% to $82,000 from the year-ago level.

Hong Kong revenues fell 18.4% to $6.3 million from $7.7 million, reflecting weakness in NHTC's largest market.

NHTC's Other Key Metrics

Gross profit margin improved to 74.2% from 73.7% in the prior-year quarter, primarily benefiting from the shift of manufacturing activities to East Asia.

Commissions expense represented 35.9% of revenues, down from 40.9% a year earlier. Selling, general and administrative expenses declined 12% to $3.2 million from $3.6 million.

Operating loss narrowed to $0.3 million from $0.5 million in the corresponding period last year.

The Primary Reporting Unit generated segment operating income of $1.3 million compared with $1.2 million in the year-ago quarter. Meanwhile, China's segment operating loss widened to $0.2 million from $0.1 million. The contrasting performance highlights NHTC's uneven profitability across its reporting segments despite ongoing cost-reduction initiatives.

Active Members totaled 27,040 as of Sept. 30, 2026, compared with 28,030 as of Sept. 30, 2025, but increased from 26,000 as of June 30, 2026.

For the first nine months of 2026, revenues declined 18.8% to $24.4 million from $30 million. Net loss widened to $0.8 million from $0.3 million.

Net cash used in operating activities narrowed to $3.3 million from $5 million in the prior-year period. Cash, cash equivalents and marketable securities totaled $17.6 million as of Sept. 30, 2026, compared with $28.9 million as of Dec. 31, 2025.

Natural Health repurchased 28,022 common shares during the third quarter and an additional 57,269 shares in October 2026. The board subsequently authorized additional repurchases under the existing program, with $15.8 million remaining available. The continued buyback authorization reflects management's emphasis on shareholder returns despite declining revenues and ongoing operating losses.

Natural Health’s Management Commentary

President Chris Sharng highlighted persistent consumer pessimism, regulatory uncertainty and member conduct issues affecting purchasing activity in China.

Management introduced additional incentives and lower-priced product packages to support member engagement. These initiatives helped stabilize sequential revenues and increase Active Members, although they contributed to the year-over-year revenue decline.

The company's 25th anniversary celebration in Hong Kong attracted approximately 1,000 participants. Natural Health also introduced an AI-powered marketing and communication application for Chinese members to strengthen engagement and product-related communication.

Factors Affecting NHTC's Results

Weak consumer confidence in China remained a significant revenue headwind. Regulatory uncertainty surrounding direct-selling activities and disciplinary actions involving independent members further disrupted business operations.

Hong Kong accounted for 83.3% of total third-quarter 2026 revenues compared with 81.4% in the year-ago period. Substantially all revenues generated through Hong Kong were derived from products delivered to members in China. This significant geographic concentration leaves Natural Health particularly exposed to changes in Chinese consumer demand and the regulatory environment.

Meanwhile, restructuring measures implemented in late 2025 supported improved profitability. Management reported operating expense reductions of almost $0.5 million during the third quarter and cumulative savings of $1.1 million for the first nine months.

Lower commission expenses and manufacturing changes partially offset the impact of declining sales. However, promotional initiatives affected margins sequentially, with gross profit margin declining from 75.2% in the second quarter.

Natural Health’s Outlook

Natural Health expects its restructuring initiatives to generate approximately $1.5 million in annualized cost savings, although the timing of realization remains uncertain.

NHTC plans to introduce Move Prime, a joint-health supplement, alongside a traditional Chinese medicine product for its China market in the coming months.

Management also intends to prioritize financial discipline, digital tools and product innovation. No specific fourth-quarter 2026 or full-year revenue or earnings guidance was provided.

NHTC's Other Developments

Natural Health continued implementing its previously announced restructuring program, involving workforce optimization, manufacturing relocation to Asia and office downsizing. The major restructuring initiatives were substantially completed in late 2025, with cost benefits continuing into the reported quarter.